Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12076
PharmaCyte Biotech
PMCB
$5.9M
| $23K | ﹤0.01% |
18,406
-16,075
| -47% | -$26.1K |
|
12077
Asia Pacific Wire & Cable
APWC
$61.8M
| $23K | ﹤0.01% |
+15,123
| New | +$23.3K |
|
12078
Bullfrog AI
BFRG
$11M
| $22.9K | ﹤0.01% |
+13,859
| New | +$32K |
|
|
IRD
12079
Opus Genetics
IRD
$309M
| $22.7K | ﹤0.01% |
+23,099
| New | +$25.8K |
|
12080
Compugen
CGEN
$228M
| $22.6K | ﹤0.01% |
+15,494
| New | +$30.2K |
|
|
KYNB
12081
PUT
Kyntra Bio
KYNB
$28.5M
| $22.5K | ﹤0.01% |
2,900
+268
| +10% | +$3.21K |
|
12082
PUT
W&T Offshore
WTI
$546M
| $22.5K | ﹤0.01% |
14,500
-600
| -4% | -$990 |
|
|
NB
12083
PUT
NioCorp Developments
NB
$745M
| $22.5K | ﹤0.01% |
11,400
+1,400
| +14% | +$2.81K |
|
|
IMMP
12084
PUT
Immutep
IMMP
$59.5M
| $22.4K | ﹤0.01% |
12,700
-34,500
| -73% | -$66.4K |
|
|
DRRX
12085
CALL
DELISTED
DURECT Corp
DRRX
| $22.3K | ﹤0.01% |
27,900
-25,200
| -47% | -$20.3K |
|
|
LDTC
12086
DELISTED
LeddarTech
LDTC
| $22.2K | ﹤0.01% |
48,338
| – | – |
|
|
ENZ
12087
DELISTED
Enzo Biochem, Inc.
ENZ
| $22.2K | ﹤0.01% |
60,041
+26,206
| +77% | +$14.5K |
|
|
VTYX
12088
PUT
DELISTED
Ventyx Biosciences
VTYX
| $22.1K | ﹤0.01% |
19,200
-69,700
| -78% | -$120K |
|
|
UBX
12089
PUT
DELISTED
Unity Biotechnology
UBX
| $22K | ﹤0.01% |
+21,200
| New | +$38.3K |
|
12090
CALL
Alto Neuroscience
ANRO
$1.26B
| $22K | ﹤0.01% |
10,200
-1,400
| -12% | -$5.01K |
|
|
YQ
12091
PUT
17 Education & Technology Group
YQ
$23.2M
| $21.8K | ﹤0.01% |
+11,300
| New | +$21.4K |
|
12092
PUT
Invivyd
IVVD
$202M
| $21.6K | ﹤0.01% |
+35,400
| New | +$31.8K |
|
12093
OPAL Fuels
OPAL
$67.7M
| $21.6K | ﹤0.01% |
11,728
-13,491
| -53% | -$36.9K |
|
12094
PUT
Purple Innovation
PRPL
$28.7M
| $21.4K | ﹤0.01% |
1,128
-92
| -8% | -$2.12K |
|
12095
PUT
Outlook Therapeutics
OTLK
$166M
| $21.2K | ﹤0.01% |
+17,400
| New | +$30.5K |
|
12096
Generation Income Properties
GIPR
$727K
| $21.2K | ﹤0.01% |
+1,326
| New | +$22.6K |
|
12097
CALL
Lexicon Pharmaceuticals
LXRX
$1.04B
| $21.2K | ﹤0.01% |
+46,100
| New | +$29.1K |
|
12098
PUT
Skye Bioscience
SKYE
$19M
| $21.1K | ﹤0.01% |
+13,300
| New | +$36.3K |
|
|
TOUR
12099
PUT
Tuniu
TOUR
$54.4M
| $21K | ﹤0.01% |
+1,910
| New | +$19.7K |
|
12100
Rani Therapeutics
RANI
$89.7M
| $20.9K | ﹤0.01% |
+16,554
| New | +$24.5K |
|
Similar funds
Susquehanna International Group's Q1 2025 Portfolio in Review
As of Q1 2025, Susquehanna International Group held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Susquehanna International Group withdrew a net $24.4B in Q1 2025, closing 1,483 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Susquehanna International Group opened a new position in Brookfield Asset Management worth $86M.
- Susquehanna International Group's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Susquehanna International Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Susquehanna International Group's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Susquehanna International Group fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Susquehanna International Group's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Susquehanna International Group opened 1,775 new positions and closed 1,483 in Q1 2025.
- Susquehanna International Group's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.